Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.

MLA

Kramer, Andreas H., et al. “Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.” Neurocritical Care, vol. 23, no. 3, Dec. 2015, pp. 386–93. EBSCOhost, https://doi.org/10.1007/s12028-015-0126-9.

APA

Kramer, A. H., Jenne, C., Holodinsky, J. K., Todd, S., Roberts, D. J., Kubes, P., Zygun, D. A., Hill, M. D., Leger, C., & Wong, J. H. (2015). Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain. Neurocritical Care, 23(3), 386–393. https://doi.org/10.1007/s12028-015-0126-9

Chicago

Kramer, Andreas H, Craig Jenne, Jessalyn K Holodinsky, Stephanie Todd, Derek J Roberts, Paul Kubes, David A Zygun, Michael D Hill, Caroline Leger, and John H Wong. 2015. “Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.” Neurocritical Care 23 (3): 386–93. doi:10.1007/s12028-015-0126-9.